BTK Inhibitors for Waldenström’s Macroglobulinemia: Comparisons, Benefits, and the Future
source: shutterstock.com

BTK Inhibitors for Waldenström’s Macroglobulinemia: Comparisons, Benefits, and the Future

According to a story from AJMC, a recent critical review evaluated the class of therapies known as Bruton tyrosine kinase (BTK) inhibitors and their use in the treatment of Waldenström's…

Continue Reading BTK Inhibitors for Waldenström’s Macroglobulinemia: Comparisons, Benefits, and the Future